The contractor shall carry out activities required for the optimization, development, and synthesis of lead candidates and analogs, which may include resynthesis, acquisition, or purchase of…
Ended Awarded Last action
- Contract number
- 75N93018F00034
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,997,772
Award facts
- Contract value 100% obligated
- $1,997,772.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,190 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,999,962 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit organization, to carry out activities required for the optimization, development, and synthesis of lead candidates and analogs related to in vitro testing of HIV therapeutics and topical microbicides. The contract has a potential value of $1,997,772.21 and a completion date of February 28, 2021. This award is not associated with any set-aside designation. Southern Research Institute has previously supported federal agencies including NIH, CDC, DoD, and EPA through prime and subcontract awards for drug discovery, assay development, and other research and development services.
Description
The contractor shall carry out activities required for the optimization, development, and synthesis of lead candidates and analogs, which may include resynthesis, acquisition, or purchase of compounds.
Quick answers
Who was awarded contract 75N93018F00034?
75N93018F00034 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2018.
How much is contract 75N93018F00034 worth?
The government has obligated $1,997,772 on 75N93018F00034.
Is contract 75N93018F00034 an order under another contract?
Yes. 75N93018F00034 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93018F00034 competed?
The extent of competition for 75N93018F00034 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award